401 related articles for article (PubMed ID: 10440302)
1. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Gastric Cancer Surgical Study Group.
Nakajima T; Nashimoto A; Kitamura M; Kito T; Iwanaga T; Okabayashi K; Goto M
Lancet; 1999 Jul; 354(9175):273-7. PubMed ID: 10440302
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2.
Miyashiro I; Furukawa H; Sasako M; Yamamoto S; Nashimoto A; Nakajima T; Kinoshita T; Kobayashi O; Arai K;
Gastric Cancer; 2011 Aug; 14(3):212-8. PubMed ID: 21336855
[TBL] [Abstract][Full Text] [Related]
4. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of adjuvant UFT for gastric cancer.
Nakajima T
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):82-6. PubMed ID: 11098502
[TBL] [Abstract][Full Text] [Related]
6. [Multihospital co-operative study of post-operative adjuvant chemotherapy in the treatment of gastric cancer-(Part 3). Comparisons between tegafur and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Arima S; Yamamoto H; Hisatsugu T; Ohkuma R; Ohsato K; Abe R; Nakamura Y; Fukuyama N; Yamanouchi A; Taira A
Gan To Kagaku Ryoho; 1991 Mar; 18(3):443-9. PubMed ID: 1900685
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ; Kim YW; Yang HK; Chung HC; Park YK; Lee KH; Lee KW; Kim YH; Noh SI; Cho JY; Mok YJ; Kim YH; Ji J; Yeh TS; Button P; Sirzén F; Noh SH;
Lancet; 2012 Jan; 379(9813):315-21. PubMed ID: 22226517
[TBL] [Abstract][Full Text] [Related]
8. Randomized study with mitomycin C + 5-fluorouracil+cytosine arabinoside (MFC)+5-fluorouracil, MFC+tegafur and uracil (UFT), and MF+UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan.
Furukawa H; Iwanaga T; Nakajima T; Okabayashi K; Nakazato H; Hiratsuka M; Ohta K; Kito T; Yamamura Y; Goto S
J Surg Oncol; 1995 Sep; 60(1):59-64. PubMed ID: 7666668
[TBL] [Abstract][Full Text] [Related]
9. Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
J Surg Oncol; 2000 Sep; 75(1):31-6. PubMed ID: 11025459
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
11. [Multihospital randomized study on adjuvant chemotherapy with mitomycin C and futraful or UFT in gastric cancer--(Part 2). Comparisons between futraful and UFT. North Kyushu Co-operative Study Group for Cancer Chemotherapy].
Kuroda Y; Arima S; Ohsato K; Ohkuma R; Fukuyama N; Yamanouchi A; Hisatsugu T; Yamamoto H; Nakamura Y; Abe R
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2235-40. PubMed ID: 2500069
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
13. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study.
Boku N; Yamamoto S; Fukuda H; Shirao K; Doi T; Sawaki A; Koizumi W; Saito H; Yamaguchi K; Takiuchi H; Nasu J; Ohtsu A;
Lancet Oncol; 2009 Nov; 10(11):1063-9. PubMed ID: 19818685
[TBL] [Abstract][Full Text] [Related]
14. Oral tegafur-uracil plus folinic acid versus intravenous 5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer.
Kim DJ; Kim TI; Suh JH; Cho YS; Shin SK; Kang JK; Kim NK; Kim WH
Yonsei Med J; 2003 Aug; 44(4):665-75. PubMed ID: 12950123
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.
Ahn MS; Kang SY; Lee HW; Jeong SH; Park JS; Lee KJ; Cho YK; Han SU; Lee SY; Lim HY; Choi JH
Onkologie; 2013; 36(7-8):421-6. PubMed ID: 23921761
[TBL] [Abstract][Full Text] [Related]
16. A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer.
Kurihara M; Izumi T; Yoshida S; Ohkubo T; Suga S; Kiyohashi A; Yaosaka T; Takahashi H; Ito T; Sasai T
Jpn J Cancer Res; 1991 May; 82(5):613-20. PubMed ID: 1905707
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.
Nakajima T; Kinoshita T; Nashimoto A; Sairenji M; Yamaguchi T; Sakamoto J; Fujiya T; Inada T; Sasako M; Ohashi Y;
Br J Surg; 2007 Dec; 94(12):1468-76. PubMed ID: 17948223
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for high-grade advanced gastric cancer.
Yonemura Y; Sawa T; Kinoshita K; Matsuki N; Fushida S; Tanaka S; Ohoyama S; Takashima T; Kimura H; Kamata T
World J Surg; 1993; 17(2):256-61; discussion 261-2. PubMed ID: 8511923
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A; Shimada Y; Shirao K; Boku N; Hyodo I; Saito H; Yamamichi N; Miyata Y; Ikeda N; Yamamoto S; Fukuda H; Yoshida S;
J Clin Oncol; 2003 Jan; 21(1):54-9. PubMed ID: 12506170
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer.
Grau JJ; Estapé J; Fuster J; Filella X; Visa J; Terés J; Soler G; Albiol S; García-Valdecasas JC; Grande L; Bombí J; Bordas J; Alcobendas F
J Clin Oncol; 1998 Mar; 16(3):1036-9. PubMed ID: 9508188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]